GE HealthCare Technologies (GEHC) Change in Receivables (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Change in Receivables came in at $79.0 million in Q2 2026, up 175.96% YoY from $28.6 million in Q2 2025, and up 156.03% on a QoQ basis from -$141.0 million in Q1 2026.
GE HealthCare Technologies (GEHC) Change in Receivables (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Change in Receivables data on file, last reported at $79.0 million in Q2 2026.
- Quarterly Change in Receivables rose 175.96% year-over-year to $79.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $339.0 million (up 245.92% YoY) and the FY2025 annual result came in at $216.0 million, up 37.58% from the prior year.
- Change in Receivables improved to $79.0 million in Q2 2026, from -$141.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $258.0 million in Q4 2024 to a low of -$165.0 million in Q1 2024.
- A 5-year average of $39.7 million and a median of $32.0 million in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables tumbled 850.0% — and 2025, when it jumped 664.0%.
- Tracing GEHC's Change in Receivables over 5 years: stood at $124.0 million in 2022, then fell by 26.61% to $91.0 million in 2023, then jumped by 183.52% to $258.0 million in 2024, then dropped by 18.6% to $210.0 million in 2025, then plunged by 62.38% to $79.0 million in 2026.
- The last three Change in Receivables figures came in at $79.0 million (Q2 2026), -$141.0 million (Q1 2026), and $210.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 38.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79.00 Mn |
| Jun 30, 2026 | 79.00 Mn |
| Mar 31, 2026 | -141.00 Mn |
| Mar 31, 2026 | -141.00 Mn |
| Dec 31, 2025 | 210.00 Mn |
| Dec 31, 2025 | 210.00 Mn |
| Sep 30, 2025 | 191.00 Mn |
| Sep 30, 2025 | 191.00 Mn |
| Jun 30, 2025 | -104.00 Mn |
| Jun 30, 2025 | -104.00 Mn |
| Mar 31, 2025 | -81.00 Mn |
| Mar 31, 2025 | -81.00 Mn |
| Dec 31, 2024 | 258.00 Mn |
| Dec 31, 2024 | 258.00 Mn |
| Sep 30, 2024 | 25.00 Mn |
| Sep 30, 2024 | 25.00 Mn |
| Jun 30, 2024 | 39.00 Mn |
| Jun 30, 2024 | 39.00 Mn |
| Mar 31, 2024 | -165.00 Mn |
| Mar 31, 2024 | -165.00 Mn |